Alnylam all set for givosiran phase 3 acute hepatic porphyrias trial
Clinical trial news : Alnylam Pharmaceuticals said that it has wrapped up enrollment of patients for a phase 3 trial
Continue readingCoverage of Global Pharma Industry News
Clinical trial news : Alnylam Pharmaceuticals said that it has wrapped up enrollment of patients for a phase 3 trial
Continue readingAravive Biologics has secured fast track designation from the US Food and Drug Administration (FDA) for its ovarian cancer drug
Continue readingCEQUA FDA approval : Sun Pharmaceutical Industries has secured approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the US Food
Continue readingBioNTech, a German biotechnology company, has joined forces with US pharma giant Pfizer to develop mRNA-based flu vaccines as part
Continue readingThe US Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) by Regeneron Pharmaceuticals for EYLEA
Continue readingTeva Pharmaceutical Industries and Regeneron Pharmaceuticals said that a phase 3 study evaluating nerve growth factor (NGF) antibody fasinumab in
Continue readingTolero Pharmaceuticals said that its cyclin-dependent kinase 9 (CDK9) inhibitor alvocidib will be combined with AbbVie leukemia drug venetoclax to
Continue readingLenvima FDA appoval : Eisai and Merck announced that the US Food and Drug Administration (FDA) has approved their kinase
Continue readingOrchard Therapeutics, a UK and US based gene therapy company, has secured $150 million of new capital through a Series
Continue readingArray BioPharma secured breakthrough therapy designation from the U.S. Food and Drug Administration (FDA) for encorafenib (BRAFTOVI), in combination with
Continue reading